Unresolved disorder model. using A ATOM 169 N AVAL 22 24.251 -20.687 1.454 0.50 19.69 N Unresolved disorder model. using A ATOM 170 N BVAL 22 24.272 -20.691 1.448 0.50 19.56 N Unresolved disorder model. using A ATOM 171 CA AVAL 22 23.553 -20.139 2.593 0.50 18.35 C Unresolved disorder model. using A ATOM 172 CA BVAL 22 23.605 -20.125 2.599 0.50 17.98 C Unresolved disorder model. using A ATOM 173 C AVAL 22 24.298 -18.878 2.984 0.50 19.46 C Unresolved disorder model. using A ATOM 174 C BVAL 22 24.327 -18.858 2.970 0.50 19.34 C Unresolved disorder model. using A ATOM 175 O AVAL 22 25.546 -18.852 2.964 0.50 18.99 O Unresolved disorder model. using A ATOM 176 O BVAL 22 25.582 -18.818 2.956 0.50 18.88 O Unresolved disorder model. using A ATOM 177 CB AVAL 22 23.502 -21.154 3.772 0.50 17.20 C Unresolved disorder model. using A ATOM 178 CB BVAL 22 23.643 -21.082 3.816 0.50 16.79 C Unresolved disorder model. using A ATOM 179 CG1AVAL 22 23.096 -20.462 5.028 0.50 20.36 C Unresolved disorder model. using A ATOM 180 CG1BVAL 22 22.746 -22.291 3.580 0.50 16.29 C Unresolved disorder model. using A ATOM 181 CG2AVAL 22 22.481 -22.249 3.510 0.50 13.88 C Unresolved disorder model. using A ATOM 182 CG2BVAL 22 25.096 -21.456 4.197 0.50 14.40 C Unresolved disorder model. using A ATOM 841 CA AASP 108 26.357 -38.115 17.801 0.50 29.31 C Unresolved disorder model. using A ATOM 842 CA BASP 108 26.356 -38.115 17.801 0.50 29.69 C Unresolved disorder model. using A ATOM 844 O AASP 108 24.785 -39.339 16.473 0.50 28.43 O Unresolved disorder model. using A ATOM 845 O BASP 108 24.785 -39.338 16.473 0.50 28.60 O Unresolved disorder model. using A ATOM 846 CB AASP 108 25.835 -38.596 19.155 0.50 31.37 C Unresolved disorder model. using A ATOM 847 CB BASP 108 25.834 -38.596 19.154 0.50 32.27 C Unresolved disorder model. using A ATOM 848 CG AASP 108 26.179 -40.047 19.429 0.00 36.57 C Unresolved disorder model. using A ATOM 849 CG BASP 108 26.233 -37.678 20.293 0.50 33.09 C Unresolved disorder model. using A ATOM 850 OD1AASP 108 27.382 -40.361 19.547 0.00 40.50 O Unresolved disorder model. using A ATOM 851 OD1BASP 108 27.254 -36.972 20.159 0.50 38.48 O Unresolved disorder model. using A ATOM 852 OD2AASP 108 25.247 -40.872 19.528 0.00 41.43 O Unresolved disorder model. using A ATOM 853 OD2BASP 108 25.524 -37.662 21.322 0.50 36.81 O Unresolved disorder model. using A ATOM 1191 CA ALEU 151 6.435 -29.834 -6.820 0.50 17.63 C Unresolved disorder model. using A ATOM 1192 CA BLEU 151 6.442 -29.834 -6.823 0.50 17.64 C Unresolved disorder model. using A ATOM 1195 CB ALEU 151 5.652 -30.545 -7.902 0.50 19.21 C Unresolved disorder model. using A ATOM 1196 CB BLEU 151 5.679 -30.536 -7.922 0.50 19.17 C Unresolved disorder model. using A ATOM 1197 CG ALEU 151 6.116 -30.399 -9.328 0.50 21.96 C Unresolved disorder model. using A ATOM 1198 CG BLEU 151 6.222 -30.400 -9.321 0.50 21.88 C Unresolved disorder model. using A ATOM 1199 CD1ALEU 151 5.458 -31.478 -10.155 0.50 23.60 C Unresolved disorder model. using A ATOM 1200 CD1BLEU 151 5.633 -31.500 -10.159 0.50 23.92 C Unresolved disorder model. using A ATOM 1201 CD2ALEU 151 5.657 -29.012 -9.728 0.50 25.86 C Unresolved disorder model. using A ATOM 1202 CD2BLEU 151 5.766 -29.023 -9.760 0.50 26.24 C 1